Omicron-fuelled volatility deals hedge funds worst monthly return since March 2020


Shares of Moderna, for example, which Sears said some hedge funds had bet against, jumped 30% between Nov. 18 and Nov. 30. Prior to Nov. 18, short interest in Moderna amounted to 14.4 million shares, or 4.1% of the float, according to data from S3 Partners.

TORONTO: Omicron-fuelled market swings appear to have made November the worst month for global hedge fund performance since the virus first shut down economies at the start of the COVID-19 pandemic.

Hedge funds are down an estimated 1.6% to 2% in November, according to early data from industry research firm PivotalPath, their worst monthly performance since March 2020.

The potential losses are a setback in what has so far been a steady year for performance. The average hedge fund is up 11.4% in the first 10 months of 2021, data from HedgeFund Research (HFR) showed. That compares to 11.8% last year and 10.5% in 2019.

The losses are “quite widespread", said Robert Sears, chief investment officer of London-based Capital Generation Partners, which invests in hedge funds. "A few of our managers got a little bit of positive performance but I think, in aggregate, it's going to be down."

The S&P 500 fell 3.9% from its record high in November as Omicron worries hit stocks in the month’s final days, and notched a nearly 1% loss for the month as a whole. Some areas of the market, however, were harder hit, with the S&P’s energy sector losing 6.2% last month and financials losing 5.9%.

November also saw volatility rise across asset classes, with uncertainty over Federal Reserve monetary policy driving swings in bond and currency markets, as well as stocks.

The market swings wrongfooted some equity-focused funds, which were hit by losses in bearish bets against stocks that unexpectedly rebounded.

Jean Baptiste Berthon, senior strategist at Paris-based Lyxor Asset Management, which invests in hedge funds, said European and U.S. long-short strategies lost around 1.5% to 2% between Nov. 25 and Dec. 1.

Shares of Moderna, for example, which Sears said some hedge funds had bet against, jumped 30% between Nov. 18 and Nov. 30. Prior to Nov. 18, short interest in Moderna amounted to 14.4 million shares, or 4.1% of the float, according to data from S3 Partners.

Computer-driven trend-following hedge funds, meanwhile, suffered a "significant" performance drop of 4% to 5% between Nov. 25 and Dec. 1, with losses in fixed income, commodities and equities, creating a "perfect storm", said Berthon.

So-called 'macro' hedge funds, which bet on macroeconomic trends, lost closer to 2%, mainly from bond positioning, while merger-arbitrage funds, which make calls on deals, were marginally up, he added.

Some hedge funds are likely to pull back on risk this month, in an effort to preserve returns in what has for many been a solid year, Berthon said.

"We're now three weeks before the end of the year, so it's unlikely we'll see funds trying to be heroes and trying to re-instate major play to capture the rebound," he said.- Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Hedge funds , Omicron , shares , Moderna ,

   

Next In Business News

Ringgit opens marginally higher on mixed signals
Strong dividend outlook on Hap Seng Plantations
Hibiscus completes acquisition of Fortuna international Petroleum
FBM KLCI slumps following wild trading on Wall Street
Trading ideas: Opcom, Maybank, Greatech Technology, MISC, Luster Industries, Aimflex, AirAsia and YB Ventures
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study
Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
Oil price falls 2% as Fed rate hike talk spooks risk markets
Bitcoin bounces off six month lows as buyers step in
Wall Street reverses, ends higher in late session rally

Others Also Read


Vouchers